文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

细胞因子和趋化因子作为前列腺癌转移的介质。

Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis.

机构信息

Julius L. Chambers Biomedical/Biotechnology Institute and Department of Biological & Biomedical Sciences, North Carolina Central University, Durham, NC 27707, USA.

出版信息

Int J Mol Sci. 2020 Jun 23;21(12):4449. doi: 10.3390/ijms21124449.


DOI:10.3390/ijms21124449
PMID:32585812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7352203/
Abstract

The consequences of prostate cancer metastasis remain severe, with huge impact on the mortality and overall quality of life of affected patients. Despite the convoluted interplay and cross talk between various cell types and secreted factors in the metastatic process, cytokine and chemokines, along with their receptors and signaling axis, constitute important factors that help drive the sequence of events that lead to metastasis of prostate cancer. These proteins are involved in extracellular matrix remodeling, epithelial-mesenchymal-transition, angiogenesis, tumor invasion, premetastatic niche creation, extravasation, re-establishment of tumor cells in secondary organs as well as the remodeling of the metastatic tumor microenvironment. This review presents an overview of the main cytokines/chemokines, including IL-6, CXCL12, TGFβ, CXCL8, VEGF, RANKL, CCL2, CX3CL1, IL-1, IL-7, CXCL1, and CXCL16, that exert modulatory roles in prostate cancer metastasis. We also provide extensive description of their aberrant expression patterns in both advanced disease states and metastatic sites, as well as their functional involvement in the various stages of the prostate cancer metastatic process.

摘要

前列腺癌转移的后果仍然严重,对受影响患者的死亡率和整体生活质量产生巨大影响。尽管在转移过程中各种细胞类型和分泌因子之间存在复杂的相互作用和串扰,但细胞因子和趋化因子及其受体和信号轴仍然是重要的因素,有助于驱动导致前列腺癌转移的一系列事件。这些蛋白参与细胞外基质重塑、上皮-间充质转化、血管生成、肿瘤侵袭、前转移龛形成、外渗、肿瘤细胞在次级器官中的重新建立以及转移瘤微环境的重塑。这篇综述概述了主要的细胞因子/趋化因子,包括 IL-6、CXCL12、TGFβ、CXCL8、VEGF、RANKL、CCL2、CX3CL1、IL-1、IL-7、CXCL1 和 CXCL16,它们在前列腺癌转移中发挥调节作用。我们还广泛描述了它们在晚期疾病状态和转移部位的异常表达模式,以及它们在前列腺癌转移过程的各个阶段中的功能参与。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac6/7352203/2aaec60974e0/ijms-21-04449-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac6/7352203/2aaec60974e0/ijms-21-04449-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac6/7352203/2aaec60974e0/ijms-21-04449-g001.jpg

相似文献

[1]
Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis.

Int J Mol Sci. 2020-6-23

[2]
The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.

Cell Mol Biol Lett. 2024-5-14

[3]
Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update.

Urol Oncol. 2021-1

[4]
The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases.

Front Immunol. 2020

[5]
Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis.

Semin Cancer Biol. 2022-11

[6]
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.

J Exp Clin Cancer Res. 2019-11-12

[7]
The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.

J Exp Ther Oncol. 2004-12

[8]
Inflammatory chemokines and metastasis--tracing the accessory.

Oncogene. 2013-7-15

[9]
The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers.

Cancer Metastasis Rev. 2021-6

[10]
Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.

Mol Cancer. 2021-1-4

引用本文的文献

[1]
Unraveling the role of M2 TAMs in ovarian cancer dynamics: a systematic review.

J Transl Med. 2025-6-3

[2]
Comparative Analysis of Cytokine Expression Profiles in Prostate Cancer Patients.

Biology (Basel). 2025-5-6

[3]
Phytochemical characterization and therapeutic mechanism of Xialiqi capsule on benign prostatic hyperplasia.

Naunyn Schmiedebergs Arch Pharmacol. 2025-4-14

[4]
Exploring TGF-β signaling in benign prostatic hyperplasia: from cellular senescence to fibrosis and therapeutic implications.

Biogerontology. 2025-3-30

[5]
The Role and Potential of Modern Radiotherapy in the Treatment of Metastatic Prostate Cancer.

Cancers (Basel). 2025-3-20

[6]
Prostate Cancer Bone Metastasis: Molecular Mechanisms of Tumor and Bone Microenvironment.

Cancer Manag Res. 2025-2-1

[7]
The heat of the battle: inflammation's role in prostate cancer development and inflammation-targeted therapies.

Discov Oncol. 2025-2-1

[8]
The Therapeutic Potential of Physical Exercise in Cancer: The Role of Chemokines.

Int J Mol Sci. 2024-12-23

[9]
CXCR1 Expression in MDA-PCa-2b Cell Upregulates ITM2A to Inhibit Tumor Growth.

Cancers (Basel). 2024-12-11

[10]
The Immune Microenvironment in Prostate Cancer: A Comprehensive Review.

Oncology. 2024-10-9

本文引用的文献

[1]
Molecular principles of metastasis: a hallmark of cancer revisited.

Signal Transduct Target Ther. 2020-3-12

[2]
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer.

Sci Transl Med. 2019-12-4

[3]
IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer.

Mol Cancer Res. 2019-10-11

[4]
CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition.

Cell Commun Signal. 2019-9-10

[5]
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Medicines (Basel). 2019-7-30

[6]
TGF-BETA IN THE NATURAL HISTORY OF PROSTATE CANCER.

Acta Clin Croat. 2019-3

[7]
Activator of G protein signaling 3 modulates prostate tumor development and progression.

Carcinogenesis. 2019-12-31

[8]
TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.

Int J Mol Sci. 2019-6-5

[9]
Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition.

Sci Rep. 2019-5-6

[10]
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer.

Cancer Res. 2019-4-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索